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Abstract
Purpose This study aimed to determine whether MSAF is
associated with endometritis after delivery.
Methods This cohort study was conducted from 2012 to
2013 in Kosar Hospital of Qazvin, Iran. All women with
cesarean delivery (1239 women) beyond 37 weeks of
gestational age participated in the study. Data were col-
lected on rates of endomyometritis, quality of amniotic
fluid and were analyzed with bivariate and multivariate
statistics. Probability values of\.05 were considered sta-
tistically significant.
Results We found that among 1239 women with cesarean
delivery at term 2.34 % were diagnosed with endometritis.
Compared with deliveries with clear amniotic fluid, those
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with MSAF had higher rates of endomyometritis (1.5 vs
3.2 %, P\ .04).
Conclusion We found that the presence of MSAF is
associated with puerperal infection even when being con-
trolled for confounders.
Keywords Meconium  Amniotic fluid 
Puerperal infection  Endomyometritis
Introduction
Meconium-stained amniotic fluid (MSAF), as a result of
the passage of fetal colonic contents into the amniotic
cavity, occurs in 15–20 % of term, and up to 40 % of post-
term pregnancies [1]. The incidence of MSAF is less than
5 % in preterm pregnancies [2].
MSAF may act directly and indirectly on exposed tissue.
Its effects depend on the concentration ofmeconium, duration
of exposure, and the presence of associated stress factors
(hypoxia, infection).MSAFhas been linkedwith an increased
risk of developing chorioamnionitis endometritis and higher
rate of cesarean section and is associated with adverse fetal
outcomes including meconium aspiration syndrome (MAS),
admission to neonatal intensive care unit (NICU), neonatal
sepsis, cerebral palsy, seizure, and pulmonary diseases [2–5].
Meconium aspiration syndrome is the most serious of these
complications and has been reported in approximately 5 % of
pregnancies complicated by meconium, with a resultant
mortality rate of approximately 5–10 % [6, 7].
The main theories of meconium passage into amniotic
fluid are physiological fetal gastrointestinal maturity or,
alternatively, a pathological process due to fetal stress such
as hypoxia or infection [7]. Although meconium appears
very early in the gastrointestinal tract, MSAF rarely occurs
before 34 weeks of gestation. Motilin, an intestinal
polypeptide which stimulates contraction of intestinal
muscle, is found in higher concentrations in post-term than
preterm fetal gastrointestinal tracts. Furthermore, intestinal
parasympathetic innervation and myelination also increase
in later gestations, implying that the increasing incidence
may reflect the maturation of peristalsis in the fetal intes-
tine. Therefore, at increasing gestations, particularly post-
term, MSAF may be a physiological event, reflecting the
maturation of fetal intestinal function. MASF has also been
attributed to stress secondary to hypoxia and infection.
Passage of meconium occurs more frequently when
umbilical vein oxygen saturations are below 30 % [8].
Several mechanisms have been proposed for meconium-
associated puerperal infections, which include alteration in
the antibacterial properties of amniotic fluid and enhanced
bacterial growth [8, 9]. The importance of a possible
association between meconium and puerperal infection is
underscored by the various complications with which
intrapartum and postpartum infections are associated.
Chorioamnionitis affects .5–2.0 % of pregnancies [8, 10].
Chorioamnionitis is also more likely to occur when MSAF
is present [11]. Maternal infection is also more likely in the
presence of MSAF. Patients with MSAF were almost two
and a half times as likely to develop postoperative
endometritis [12].
Puerperal infection rates which are associated with the
degree of meconium staining increase with rates rising as
meconium thickness [8]. Meconiummay enhance the growth
of bacteria in amniotic fluid by serving as a growth factor,
inhibiting bacteriostatic properties of amniotic fluid, or
antagonising host defense systems, thus increasing the risk of
chorioamnionitis [13]. Mechanisms of meconium-associated
puerperal infections including altering the antibacterial
properties of amniotic fluid and enhancing bacterial growth
impair the host immune response through the inhibition of
phagocytosis and neutrophil oxidative burst [14].
Only one study used multiple logistic regression analyses
to show statistically significant associations between MSAF
and both puerperal infections in term deliveries [12]. Most
of these studies had fewer than 1000 patients and did not use
multivariate analyses to control for confounding. Based on
the high prevalence of meconium passage in pregnant
women who admitted to Kosar hospital and controversial
result studies on the relationship between puerperal infec-
tion and MSAF [15, 16], the current study aimed to deter-
mine whether MSAF is associated with endometritis.
Materials and Methods
This cohort study was conducted from 2012 to 2013 in
Kosar Hospital of Qazvin, Iran. All women with cesarean
deliveries (1239 women) beyond 37 weeks of gestational
age participated in the study. Patients were divided into
two groups: 619 women with MSAF and 620 with clear
amniotic fluid. Cesarean section was performed in both
groups based on obstetric indications. It should be men-
tioned that as cesarean delivery is a risk factor for puerperal
infection, we selected the patients with cesarean methods
in order to match the two groups.
Both groups received prophylactic antibiotic which
contains 2 g of cefazolin immediately after giving birth,
and three doses as a post-surgery medicine.
The inclusion criteria were as follows: (1) women with a
single fetus; (2) cephalic presentation; (3) gestational age
of C37 weeks; and (4) birth weight C2500 g;
The exclusion criteria were as follows: (1) high-risk
pregnancy; (2) time of rupture of membranes C18 h; (3)
dead fetus in utero; (4) fetal anomaly; (5) maternal medical
diseases (including cardiovascular disease, renal disease,
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anemic pregnant women,…); (6) BMI[ 26; (7) cesarean
duration [90 min; and (8) prophylactic antibiotic given
before, during, and after delivery.
Pregnant women without MSAF were categorized as
clear amniotic fluid.
Puerperal infection is referred to any bacterial infection
of the genital tract after delivery that outbreaks with fever
of 38 degrees Celsius or higher (100.4 F) beginning after
24 h to 10 days from child birth and continues for at least
48 h. The degree was determined by measuring the fever
through mouth four times a day.
Endometritis was defined when the body temperature
was[38 C, plus uterine tenderness, foul smell lochia, or
white blood cell count more than 15,000/mm3 dm.
Data collection was done through observation and
physical examination and laboratory findings such as CBC
diff, U/A, U/C. Maternal demographic data, route, and
outcome of delivery were abstracted from the medical
records by a single investigator using standardized defini-
tion. This present research was approved by the Ethics
Committee, Qazvin University Medical Department.
Statistical Analysis
Univariate analyses of the predictor variables (clear amni-
otic fluid and MSAF) were performed for the dependent
variables of postpartum endomyometritis. Mean ± standard
deviation (SD) and frequency (%) were used to describe the
patient characteristics. Student’s t test was performed to
assess the difference between two means. Chi-square test
was used to compare categorical variables. Univariate and
multivariate analyses of risk factors (odds ratio) associated
with quality of MSAF and maternal factors were analyzed
with 95 % confidence interval (95 % CI). Probability values
\.05 were considered statistically significant.
Results
Out of a total of 1239 women who were studied, 620
patients were in the control group with clear amniotic fluid
and 619 women were in case group with MSAF. Table 1
shows the demographics and perinatal outcomes (age,
women education, gestational age, parity, duration of
rupture of membrane, birth weight, Apgar score with mean
and standard deviation) of patients with clear amniotic fluid
in comparison with those with MSAF. Statistically signif-
icant differences between the two groups included percent
of gestational age (P = .001), birth weight (P = .01), and
Apgar score (P = .04).
Table 2 shows the puerperal infection rates were in two
groups. The overall endomyometritis rate was 4.7 %.
Patients with clear amniotic fluid had a 1.5 %
endomyometritis rate; patients with MSAF had an overall
rate of 3.2 % (P = .04).
In the multivariate model (Table 3), with the use of the
MSAF as a predictor for puerperal infection, we found that
MSAF was significantly associated with increases in
endomyometritis (odds ratio 1.52; 95 % CI 1.20–1.94) and
1-min Apgar score of \7 (odds ratio 2.20; 95 % CI
1.70–2.82). In this model, we controlled for maternal age,
parity (young maternal age and nulliparity), level of edu-
cation, gestational age, birth weight, and length of labor.
Discussion
The present study reports the results of a cohort study of
MSAF and puerperal infection in Kosar Hospital, Qazvin,
Iran. We found that the presence of meconium staining was






Maternal age\35 years 24.47 ± 2.86 24.7 ± 1.84 .354
Education
Under diploma 356 (57.2 %) 360 (58.2 %) .31
Diploma 218 (35.3 %) 212 (33.1 %)
University 45 (7.3 %) 48 (8 %)
Parity
G1 524 (84.7 %) 542 (78.8 %) .116
MG 95 (15.3 %) 75 (12.2 %)
Duration of ROM (h)
C18 1 (.017 %) 1 (.017 %) .218
B18 618 (99.83 %) 619 (99.83 %)
Gestational age 39.3 ± 9 38.3 ± 3 .001
Birth weight 3300 ± .43 3230 ± .47 .01
Apgar 1 min 8 ± .8 9.06 ± .4 .04
Apgar 5 min 9.86 ± .56 9.84 ± 1.1 .68
Table 2 Infection rates by MSAF
Amniotic fluid Total deliveries Endomyometritis P value
Clear 620 1.5 .04
MSAF 619 3.2
Table 3 Comparison of MSAF as a predictor of perinatal outcome
Outcome Odds ratio 95 % CI
Endomyometritisa 1.52 1.20–1.94
One-min Apgar score,\7a 2.20 1.70–2.82
a Controlled for maternal age, parity, education, ethnicity, length of
labor, and birth weight
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associatedwith endomyometritis. This association was robust
even when controlled for multiple confounding factors that
included length of labor, gestational age, parity, birth weight,
duration of rupture of membrane, and mode of delivery.
However, previous studies reported that an association
between MSAF and infection existed. Jazayeri et al. [17]
showed that the MSAF is associated with increased
endometritis, Piper et al. [18] reported that the MSAF is
associatedwith increased peripartum infection, and Tran et al.
[8] concluded that chorioamnionitis and endomyometritis are
associated with MSAF. But Boonprasert et al. [3] and Mos-
taghel et al. [19] found no relationship between MSAF and
endomyometritis. It seems that such conflicting results about
the relationship between the MSAF and endomyometritis are
due to the differences between selected variables, the condi-
tions of the studies and the sample size, prophylactic antibi-
otic given before, during, and after delivery, and kind of
delivery which may affect the results. The present study was
controlled by multiple confounding factors such as route of
delivery, length of labor, prior antibiotic prophylaxis, and
duration of rupture of membrane in Kosar Hospital.
In the current study, a relationship was found between
gestational age and birth weight with MSAF. Balchin et al.
[20] showed that the MSAF is associated with gestational
age as well. Sedaghatian et al. [21] reported that birth
weight is associated with MSAF. It seems that with
increased gestational age and birth weight, the risk of
MSAF is also increased.
The adverse neonatal outcomes associated with MSAF
were observed in our study with 1- and 5-min Apgar scores
\7. The present study reports reduction 1-min Apgar scores
in MSAF. Meconium may decrease the neonate’s ability to
breathe on its own, particularly if MAS develops. Several
studies investigate the relationship between low Apgar
score and increased neonatal mortality with MSAF [22–24].
A Cochrane systematic review of 19 trials [25], most of
which took place in developed countries, has concluded
that a policy of routine induction of labor at 41 weeks of
gestation reduced the risk of perinatal mortality (RR .30,
95 % CI .09–.99) and MAS (RR .29, 95 % CI .12–.68)
without increasing the risk of operation. In another study,
Susan et al. [8] estimated the risk of chorioamnionitis in
MSAF (odds ratio 1.39, 95 % CI 1.20–1.61) and
endomyometritis (odds ratio 1.51, 95 % CI 1.19–1.93).
Consideration should be given to increased monitoring, or
labor induction, earlier than 41 weeks of gestation.
Conclusion
According to the results of the present study, we found that
the presence and severity of MSAF are associated with
puerperal infection even when being controlled for
confounders. It seems that accurate care to prevent infec-
tion is essential in cases of meconium passage.
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